Picture of ReproCELL Incorporated logo

4978 — ReproCELL Incorporated News Story

0.000.00%
jp flag iconLast trade - 00:00
HealthcareHighly SpeculativeSmall CapSucker Stock

Table: Reprocell -2019/20 group results

Jul 10 (Reuters)- 
          Reprocell Incorporated 
          CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                 Year ended      Year ended        Year to        NEXT   
              Mar 31, 2020    Mar 31, 2019    Mar 31, 2021      YEAR     
                 LATEST         YEAR-AGO         COMPANY       COMPANY   
                 RESULTS         RESULTS        FORECAST     H1 FORECAST 
  Sales           1.20            1.09            1.30                   
               (+10.2 pct)     (+17.5 pct)     (+8.0 pct)                
  Operating   loss 908 mln    loss 781 mln      loss 1.04                
  Recurring   loss 891 mln    loss 627 mln    loss 893 mln               
  Net
  Net           loss 1.02     loss 601 mln    loss 893 mln               
  EPS        loss 14.27 yen   loss 8.79 yen  loss 12.52 yen              
  Ann Div          NIL             NIL             NIL                   
  -Q2 Div          NIL             NIL             NIL                   
  -Q4 Div          NIL             NIL             NIL                   
  
  NOTE - Reprocell Incorporated.
  *Second Net profit row denotes profit attributable to owners ofthe parent 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4978.T

Recent news on ReproCELL Incorporated

See all news